271 related articles for article (PubMed ID: 17992493)
1. [Application of humanized Anti-IgE antibodies (omalizumab). A new principle in the treatment of allergic diseases in ENT medicine].
Pfaar O; Klimek L
HNO; 2007 Dec; 55(12):981-90; quiz 991-2. PubMed ID: 17992493
[TBL] [Abstract][Full Text] [Related]
2. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
3. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
[TBL] [Abstract][Full Text] [Related]
4. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985
[TBL] [Abstract][Full Text] [Related]
5. Etiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.
Bush RK
Treat Respir Med; 2004; 3(1):45-57. PubMed ID: 15174893
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab: Anti-IgE therapy in allergy.
Kopp MV
Curr Allergy Asthma Rep; 2011 Apr; 11(2):101-6. PubMed ID: 21243454
[TBL] [Abstract][Full Text] [Related]
7. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
Casale TB; Condemi J; LaForce C; Nayak A; Rowe M; Watrous M; McAlary M; Fowler-Taylor A; Racine A; Gupta N; Fick R; Della Cioppa G;
JAMA; 2001 Dec; 286(23):2956-67. PubMed ID: 11743836
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab for treatment of allergic rhinitis.
Vashisht P; Casale T
Expert Opin Biol Ther; 2013 Jun; 13(6):933-45. PubMed ID: 23621175
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
[TBL] [Abstract][Full Text] [Related]
10. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
Milgrom H; Berger W; Nayak A; Gupta N; Pollard S; McAlary M; Taylor AF; Rohane P
Pediatrics; 2001 Aug; 108(2):E36. PubMed ID: 11483846
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
[TBL] [Abstract][Full Text] [Related]
12. Anti-IgE treatment in allergic rhinitis.
Bayar Muluk N; Bafaqeeh SA; Cingi C
Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109674. PubMed ID: 31526939
[TBL] [Abstract][Full Text] [Related]
13. Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.
D'Amato G; Oldani V; Donner CF
Monaldi Arch Chest Dis; 2003; 59(1):25-9. PubMed ID: 14533279
[TBL] [Abstract][Full Text] [Related]
14. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
D'Amato G; Bucchioni E; Oldani V; Canonica W
Treat Respir Med; 2006; 5(6):393-8. PubMed ID: 17154668
[TBL] [Abstract][Full Text] [Related]
15. Anti-IgE antibodies for the treatment of asthma.
Buhl R
Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab in children.
Licari A; Marseglia A; Caimmi S; Castagnoli R; Foiadelli T; Barberi S; Marseglia GL
Paediatr Drugs; 2014 Dec; 16(6):491-502. PubMed ID: 25404353
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab : other indications and unanswered questions.
Mankad VS; Burks AW
Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
[TBL] [Abstract][Full Text] [Related]
18. Experience with monoclonal antibodies in allergic mediated disease: seasonal allergic rhinitis.
Casale TB
J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S84-8. PubMed ID: 11498678
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis.
Casale TB;
Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389
[TBL] [Abstract][Full Text] [Related]
20. The effect of omalizumab on nasal allergic inflammation.
Plewako H; Arvidsson M; Petruson K; Oancea I; Holmberg K; Adelroth E; Gustafsson H; Sandström T; Rak S
J Allergy Clin Immunol; 2002 Jul; 110(1):68-71. PubMed ID: 12110823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
